Search Results - "Pavia, Giulia"

Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case series by Gargiulo, Luigi, Ibba, Luciano, Pavia, Giulia, Avagliano, Jessica, Cortese, Andrea, Costanzo, Antonio, Narcisi, Alessandra

“…The overlap of psoriasis and atopic dermatitis (AD) is rare and treating moderate-to-severe cases can be challenging. Conventional immune-suppressive drugs…”
Get full text

Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study by Borroni, Riccardo G, Malagoli, Piergiorgio, Gargiulo, Luigi, Valenti, Mario, Pavia, Giulia, Facheris, Paola, Morenghi, Emanuela, Di Corteranzo, Isotta Giunipero, Narcisi, Alessandra, Ortoncelli, Michela, Dapavo, Paolo, Costanzo, Antonio

“…Risankizumab is a humanized monoclonal antibody that binds the p19 subunit of interleukin-23. It is approved for treatment of moderate-severe chronic plaque…”
Get full text

New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series by Gargiulo, Luigi, Ibba, Luciano, Vignoli, Carlo A., Piscazzi, Francesco, Cortese, Andrea, Fiorillo, Giovanni, Toso, Francesco, Pavia, Giulia, Valenti, Mario, Avagliano, Jessica, Narcisi, Alessandra, Costanzo, Antonio

Get full text

A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks by Ibba, Luciano, Gargiulo, Luigi, Pavia, Giulia, Narcisi, Alessandra, Costanzo, Antonio, Valenti, Mario

“…The development of flares or new-onset of immune-mediated dermatologic diseases, including psoriasis, has occurred with the worldwide spreading of the COVID-19…”
Get full text

Concomitant Pyoderma Gangrenosum-like and Amicrobial Pustulosis of the Folds: a Case Report by Facheris, Paola, De Santis, Maria, Gargiulo, Luigi, Pavia, Giulia, Valenti, Mario, Manara, Sofia, Borroni, Riccardo G., Costanzo, Antonio, Narcisi, Alessandra

Get full text

Risankizumab for the Treatment of Palmoplantar Pustular Psoriasis: a Report of Two Cases by Gargiulo, Luigi, Vignoli, Carlo Alberto, Pavia, Giulia, Narcisi, Alessandra, Costanzo, Antonio, Perugini, Chiara

Get full text

What Can IBD Specialists Learn from IL-23 Trials in Dermatology? by Valenti, Mario, Narcisi, Alessandra, Pavia, Giulia, Gargiulo, Luigi, Costanzo, Antonio

“…The advent of biologic drugs revolutionised the treatment of many chronic inflammatory diseases in rheumatology, dermatology, and gastroenterology. The…”
Get full text

Anti‐IL17 and anti‐IL23 biologic drugs for scalp psoriasis: A single‐center retrospective comparative study by Narcisi, Alessandra, Valenti, Mario, Cortese, Andrea, Toso, Francesco, Pavia, Giulia, Gargiulo, Luigi, Borroni, Riccardo, Costanzo, Antonio

“…Scalp is a frequent localization of psoriasis that has a massive impact on patient's quality of life. Managing this psoriasis' manifestation is often…”
Get full text

Sub‐erythrodermic psoriasis successfully treated with bimekizumab: A case report by Valenti, Mario, Gargiulo, Luigi, Ibba, Luciano, Pavia, Giulia, Narcisi, Alessandra, Costanzo, Antonio

Get full text

Non‐complicated evolution of COVID‐19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab by Valenti, Mario, Facheris, Paola, Pavia, Giulia, Gargiulo, Luigi, Borroni, Riccardo Giovanni, Costanzo, Antonio, Narcisi, Alessandra

Get full text

Impact of delay in follow‐up due to COVID‐19 pandemic on skin cancer progression: a real‐life experience from an Italian hub hospital by Valenti, Mario, Pavia, Giulia, Gargiulo, Luigi, Facheris, Paola, Nucca, Ombretta, Mancini, Luca, Sacrini, Francesco, Borroni, Riccardo G., Narcisi, Alessandra, Costanzo, Antonio

“…Background The COVID‐19 pandemic required the setting of a national lockdown in Italy from March 9, 2020, until May 18, 2020; therefore, most of the…”
Get full text

Brodalumab: A new way to inhibit IL‐17 in psoriasis by Facheris, Paola, Valenti, Mario, Pavia, Giulia, Guanziroli, Elena, Narcisi, Alessandra, Borroni, Riccardo G., Costanzo, Antonio

“…Psoriasis is a chronic inflammatory disease that affects 2% to 4% of the population; about 20% of the patients present a moderate‐to‐severe form. The…”
Get full text

A fatal case of COVID‐19 infection presenting with an erythema multiforme‐like eruption and fever by Gargiulo, Luigi, Pavia, Giulia, Facheris, Paola, Valenti, Mario, Sacrini, Francesco, Narcisi, Alessandra, Borroni, Riccardo, Costanzo, Antonio, Mancini, Luca Livio

Get full text

Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study by Gargiulo, Luigi, Ibba, Luciano, Pavia, Giulia, Vignoli, Carlo Alberto, Piscazzi, Francesco, Valenti, Mario, Sanna, Federica, Perugini, Chiara, Avagliano, Jessica, Costanzo, Antonio, Narcisi, Alessandra

“…Introduction Risankizumab is a humanized monoclonal antibody that selectively targets interleukin-23. It is approved for treatment of moderate-to-severe plaque…”
Get full text

The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV-2 infection and vaccination by Favaro, Rebecca, Formai, Alessandra, Pavia, Giulia, Gargiulo, Luigi, Avagliano, Jessica, Valenti, Mario, Facheris, Paola, Salsano, Beatrice, Latorre, Roberta V, Bellinato, Francesco, Gisondi, Paolo, Narcisi, Alessandra, Costanzo, Antonio

“…Biologic therapy for moderate-to-severe psoriasis with anti-IL-23 and anti-IL-17 does not reduce the humoral and T-cell-mediated immune responses after COVID…”
Get full text

Complicated coronavirus disease 2019 (COVID‐19) in a psoriatic patient treated with ixekizumab by Facheris, Paola, Valenti, Mario, Pavia, Giulia, Gargiulo, Luigi, Narcisi, Alessandra, Costanzo, Antonio, Borroni, Riccardo G.

Get full text

Skin cancers: how to balance the risks and benefits of surgery during COVID‐19 pandemic (a Northern Italy single‐center experience) by Pavia, Giulia, Gargiulo, Luigi, Valenti, Mario, Facheris, Paola, Nucca, Ombretta, Narcisi, Alessandra, Borroni, Riccardo G., Costanzo, Antonio

Get full text

Apremilast for the treatment of palmo‐plantar non‐pustular psoriasis: A real‐life single‐center retrospective study by Pavia, Giulia, Gargiulo, Luigi, Cortese, Andrea, Valenti, Mario, Sanna, Federica, Borroni, Riccardo G., Costanzo, Antonio, Narcisi, Alessandra

“…Palmoplantar psoriasis (PP) is a type of psoriasis that involves the skin of the palms and soles and can present as hyperkeratotic, similar to the vulgaris…”
Get full text

Deep Dermatophytosis Caused by Trichophyton verrucosum in an Immunosuppressed Patient: Successful Outcome with Terbinafine by Guanziroli, Elena, Pavia, Giulia, Guttadauro, Angelo, Sangalli, Roberta, Mancini, Luca Livio, Costanzo, Antonio

Get full text

Connective tissue panniculitis and vitiligo in a with patient stage IV melanoma achieving complete response to dabrafenib and trametinib combination therapy by Gargiulo, Luigi, Chiara Tronconi, Maria, Grimaudo, Maria S., Pavia, Giulia, Valenti, Mario, Manara, Sofia, Costanzo, Antonio, Borroni, Riccardo G.

“…The combination of BRAF and MEK inhibitors, such as dabrafenib and trametinib, respectively, is an established treatment option for patients with advanced…”
Get full text